A dysregulation in β-AR responsiveness due to increased SNS activity, with consequent catecholamine bombardment of the receptors, is associated with several pathological conditions such as stroke, hypertension, cardiac hypertrophy, and heart failure (HF) [17,18,19,20,21,22,23,24]. The gene discussed is ADRB2; the disease is cardiac hypertrophy.